Phenomix And Chiesi Partner For Phase III DPP-4 Drug In Europe
This article was originally published in The Pink Sheet Daily
Executive Summary
After the deal, Phenomix reports it has an "excellent cash position."
You may also be interested in...
Phenomix Folds After Diabetes Drug Fails To Attract Partner To Fill Forest's Shoes
DPP-4 drug dutogliptin was a casualty of the highly competitive, regulated and expensive space for diabetes drug development.
Phenomix Folds After Diabetes Drug Fails To Attract Partner To Fill Forest's Shoes
DPP-4 drug dutogliptin was a casualty of the highly competitive, regulated and expensive space for diabetes drug development.
Deals Of The Week: Pfizer/Protalix, AstraZeneca/Targacept, Chiesi/Phenomix
Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.